chloral hydrate has been researched along with Central Nervous System Disease in 1 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "Given the high bioavailability of oral chloral hydrate the major determinant of cardiotoxicity may be the dose rather than the route of administration." | 1.29 | Chloral hydrate toxicity from oral and intravenous administration. ( Amitai, Y; Erickson, T; Hryhorczuk, D; Sing, K, 1996) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Sing, K | 1 |
| Erickson, T | 1 |
| Amitai, Y | 1 |
| Hryhorczuk, D | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Intranasal Dexmedetomidine vs Oral Triclofos Sodium Sedation for Children With Autism Undergoing Electroencephalograms - A Randomized Controlled Trial.[NCT04270708] | Phase 4 | 200 participants (Anticipated) | Interventional | 2020-03-01 | Not yet recruiting | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 other study available for chloral hydrate and Central Nervous System Disease
| Article | Year |
|---|---|
Chloral hydrate toxicity from oral and intravenous administration.
Topics: Administration, Oral; Adult; Anesthetics, Intravenous; Arrhythmias, Cardiac; Central Nervous System | 1996 |